Financial, Forecast, Opportunity, Biosimilar, Medicine, Global, Healthcare, Marketplace

Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace

At the Biosimilar Drug Development World Europe event 2014, Ashwin Pai, Jefferies International, gave a presentation on “Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace.” Download and learn: Biosimilars – Where Do We Stand Today? What Does The Future Hold? Emerging Markets – Opportunity Large Than Previously Expected Developed Markets – Wide Differences Across Markets And Molecules What …

Pharma M&A Forecast Sunny

Sunny with little chance of rain: Pharma M&A forecast

Pharma M&A activity is hot out the blocks for the first quarter, with activity in the Pharma, Medical & Biotech sector totaling $63.4 billion, higher than its 2013 counterpart at $14.2 billion.   On 9th April Mergermarket released its Global Q1 2014  Pharma, Medical & Biotech M&A Trend Report,  identifying large scale growth in the pharmaceutical sector, compared to last year. …

Growth of orphan drug market puts the World Orphan Drug Congress USA in the spotlight

Differently from the uncertainty of the economic growth across developed countries, the pharmaceutical industry is optimistic about the increasing revenue from orphan drug development. In a recent report conducted by BCC Research, the orphan drug market in 2012 was evaluated in $82 billion and is expected to grow at an average rate of 5.4% in the next five years, to …